Amani Therapeutics reported raising $35 Million in an initial SEC Form D filing, from an offering of $60 Million
Round Type
Venture
Quick answer
Amani Therapeutics raised $35 Million in a funding round, dated September 16, 2026.
- How much did Amani Therapeutics raise?
- Amani Therapeutics raised $35 Million in a funding round on September 16, 2026.
- What does Amani Therapeutics do?
- Amani Therapeutics is a biotechnology company dedicated to developing highly efficacious, safer medicines for people living with serious neuropsychiatric disorders.
- Where is Amani Therapeutics based and how big is it?
- Fundz records about 11 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Amani Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Setara Biosciences raised $90M (Series A) on October 30, 2026.
- StimCardio raised $30M (Series A) on October 29, 2026.
- Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
- Tivic raised $85M (Series B) on October 27, 2026.
- VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
Who to call at Amani Therapeutics, and when
A new round usually means Amani Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Amani Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Amani Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Amani Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Amani Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Amani Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.